In order to assess if alternative p53 phosphorylation plays a role in CLL pathogenesis, we used the Zinc(II)‐Phos‐tagTM PAGE to screen the p53 phospho‐profile of 71 clinically and biologically characterized CLL cases with the intact TP53 gene (Table 1). The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.